跳至主要内容
临床试验/ITMCTR1900002368
ITMCTR1900002368招募中4 期

Effect of Guanxindanshen Dropping Pills on Quality of Life and Cardiovascular Prognosis of Patients with Depression or Anxiety after PCI for Coronary Heart Disease

Xiyuan Hospital, CACMS0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1) Voluntarily participate in the trial and sign the ICF;
  • 2) To meet the diagnostic criteria of CHD and complete PCI;
  • 3) PHQ-9 score 5-14, or GAD-7 score 5-14;
  • 4) Aged 18-75 years old, male or female;
  • 5) Be able to cooperate with examination and treatment.

排除标准

  • 1) wicked liquid condition;
  • 2) Unalleviated angina attack or NYHA cardiac function grade IV;
  • 3) electrolyte disorder, acid-base imbalance;
  • 4) Complicated with pulmonary, liver, kidney, hematopoietic system, immune system and other serious primary diseases and dysfunction;
  • 5) Organic mental disorders, depression caused by other mental disorders such as schizophrenia or somatic diseases etc.;
  • 6) Bipolar disorder, rapid circulatory seizures;
  • 7) History of epilepsy;
  • 8) Alcohol or drug abuse and drug addicts within one year;
  • 9) Other antidepressants and antianxiety drugs were taken within four weeks before the trial;
  • 10) Pregnant or lactating women or planned pregnancies;
  • 11) Those who have participated in clinical trials of other drugs within 3 months;
  • 12) Researchers do not consider it appropriate to participate in clinical trials;
  • 13) Suicide-prone patients.

研究者

发起方
Xiyuan Hospital, CACMS

相似试验